You are here :
Home
Healthcare
Payment Link for Sterlitech Corporation - Track etched Membrane Market & Pharmaceutical Filtration Market
Global Drug formulations Market Research Report
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Global Conjugate Vaccines Market The global conjugate animal vaccine market is mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $201.1 million in 2013 and is expected to reach $305.2 million by 2018 at a CAGR of 8.7% during the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac. |
Upcoming |
|
|
Global Recombinant Vaccines Market The Global Recombinant Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $368.9 million in 2013 and expected to be $550.8 million by 2018 at a CAGR of 8.3%. Recombinant Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac. |
Upcoming |
|
|
Global Dna Vaccines Market The global DNA animal vaccine market is mainly driven by growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $142.5 million in 2013 and is expected to reach $232.4 million by 2018, at a CAGR of 10.3% for the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac. |
Upcoming |
|
|
Animal Vaccines Animal Vaccines and Bacterial vaccines, Viral vaccines, |
Upcoming |
|
|
Synthetic Vaccines Synthetic Vaccines and Live Attenuated Vaccines (LAV), |
Upcoming |
|
|
Dentritic Vaccines Dentritic Vaccines and Live Attenuated Vaccines (LAV), |
Upcoming |
|
|
X-Ray Contrast Media X-Ray Contrast Media and Magnetic resonance imaging contrast media, |
Upcoming |
|
|
Barium-based contrast media Barium-based contrast media and Iodinated contrast media and |
Upcoming |
|
|
Iodinated contrast media Iodinated contrast media and Barium-based contrast media and |
Upcoming |
|
|
Gadolinium-based contrast media Gadolinium-based contrast media and Barium-based contrast media and |
Upcoming |
|
|
Acute myeloid leukemia (AML) Acute myeloid leukemia (AML) and its peer markets - Burkitt lymphoma, |
Upcoming |
|
|
Acute lymphoblastic leukemia (ALL) Acute lymphoblastic leukemia (ALL) and its peer markets - T-cell Lymphoma, |
Upcoming |
|
|
Chronic myeloid leukemia (CML) Chronic myeloid leukemia (CML) and its peer markets - Hodgkin lymphoma, |
Upcoming |
|
|
Chronic lymphocytic leukemia (CLL) Chronic lymphocytic leukemia (CLL) and its peer markets - T-cell Lymphoma, |
Upcoming |
|
|
Hodgkin lymphoma Hodgkin lymphoma and its peer markets - Burkitt lymphoma, |
Upcoming |
|
|
Hairy-cell leukemia Hairy-cell leukemia and its peer markets - Chronic lymphocytic leukemia (CLL), |
Upcoming |
|
|
Burkitt lymphoma Burkitt lymphoma and its peer markets - Chronic lymphocytic leukemia (CLL), |
Upcoming |
|
|
Adult T-cell leukemia Adult T-cell leukemia and its peer markets - Hairy-cell leukemia, |
Upcoming |
|
|
Multiple myeloma Multiple myeloma and its peer markets - Hairy-cell leukemia, |
Upcoming |
|
|
Lymphoplasmacytic lymphoma Lymphoplasmacytic lymphoma and its peer markets - Chronic myeloid leukemia (CML), |
Upcoming |
Drug formulations
